Advanced search
Publication Cover
Expert Review of Clinical Pharmacology Volume 12, 2019 - Issue 5
Submit an article Journal homepage
882
Views
24
CrossRef citations to date
0
Altmetric
Review

Novel immunotherapeutic approaches for hepatocellular carcinoma treatment

Davide BusatoExperimental and Clinical Pharmacology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano (PN), Italy;Department of Life Sciences, University of Trieste, Trieste, ItalyView further author information
,
Monica MossentaExperimental and Clinical Pharmacology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano (PN), Italy;Department of Life Sciences, University of Trieste, Trieste, ItalyView further author information
,
Lorena BabociExperimental and Clinical Pharmacology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano (PN), ItalyView further author information
,
Federica Di CintioExperimental and Clinical Pharmacology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano (PN), Italy;Department of Life Sciences, University of Trieste, Trieste, ItalyView further author information
,
Giuseppe ToffoliExperimental and Clinical Pharmacology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano (PN), ItalyCorrespondence[email protected]
View further author information
&
Michele Dal BoExperimental and Clinical Pharmacology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano (PN), ItalyView further author information
Pages 453-470 | Received 06 Feb 2019, Accepted 20 Mar 2019, Published online: 14 Apr 2019

Citations (24)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Xinge Sheng, Jingyuan Lu, Jiaqi Wang, Kaiwen Fan, Meijiao Huang & Quanyi Lu. (2023) Construction of a prognostic model of acute myeloid leukemia associated with immunogenic cell death. Expert Review of Hematology 16:7, pages 543-551.
Read now
Yang Cheng, Rui Tang, Xiangzhao Li, Biao Wang, Yanling Cheng, Shuzhe Xiao, Penghui Sun, Wenxuan Yu, Cheng Li, Xinsheng Lin & Yun Zhu. (2022) LRP1B is a Potential Biomarker for Tumor Immunogenicity and Prognosis of HCC Patients Receiving ICI Treatment. Journal of Hepatocellular Carcinoma 9, pages 203-220.
Read now
Yake Zhang, Fangyuan Xie, You Yin, Qin Zhang, Hong Jin, Yan Wu, Liying Pang, Jun Li & Jie Gao. (2021) Immunotherapy of Tumor RNA-Loaded Lipid Nanoparticles Against Hepatocellular Carcinoma. International Journal of Nanomedicine 16, pages 1553-1564.
Read now

Articles from other publishers (21)

Rong Chen, Meng Zhao, Yanli An, Dongfang Liu & Qiusha Tang. (2023) GBAP1 functions as a tumor promotor in hepatocellular carcinoma via the PI3K/AKT pathway. BMC Cancer 23:1.
Crossref
Neda Minaei, Roya Ramezankhani, Atena Tamimi, Abbas Piryaei, Ali Zarrabi, Amir Reza Aref, Ebrahim Mostafavi & Massoud Vosough. (2023) Immunotherapeutic approaches in Hepatocellular carcinoma: Building blocks of hope in near future. European Journal of Cell Biology 102:1, pages 151284.
Crossref
Piera Federico, Emilio Francesco Giunta, Andrea Tufo, Francesco Tovoli, Angelica Petrillo & Bruno Daniele. (2022) Resistance to Antiangiogenic Therapy in Hepatocellular Carcinoma: From Molecular Mechanisms to Clinical Impact. Cancers 14:24, pages 6245.
Crossref
Liangbin Cao, Lingling Zhu & Li Cheng. (2022) ncRNA-Regulated LAYN Serves as a Prognostic Biomarker and Correlates with Immune Cell Infiltration in Hepatocellular Carcinoma: A Bioinformatics Analysis. BioMed Research International 2022, pages 1-23.
Crossref
Yating Xu, Xiao Yu, Qiyao Zhang, Yuting He & Wenzhi Guo. (2022) A novel classification of HCC basing on fatty-acid-associated lncRNA. Scientific Reports 12:1.
Crossref
Davide Busato, Monica Mossenta, Michele Dal Bo, Paolo Macor & Giuseppe Toffoli. (2022) The Proteoglycan Glypican-1 as a Possible Candidate for Innovative Targeted Therapeutic Strategies for Pancreatic Ductal Adenocarcinoma. International Journal of Molecular Sciences 23:18, pages 10279.
Crossref
Jun Liu, Jianjun Lu, Wenli Li, Wenjie Mao & Yamin Lu. (2022) Machine Learning Screens Potential Drugs Targeting a Prognostic Gene Signature Associated With Proliferation in Hepatocellular Carcinoma. Frontiers in Genetics 13.
Crossref
Xiaoli Wu, Xiaoqing Meng, Tse-Shao Chang, Shuo Feng, Miki Lee, Sangeeta Jaiswal, Eun-Young K. Choi, Lam Tran, Hui Jiang & Thomas D. Wang. (2022) Multi-modal imaging for uptake of peptide ligand specific for CD44 by hepatocellular carcinoma. Photoacoustics 26, pages 100355.
Crossref
Xueyan Xi, Yang Guo, Min Zhu, Fen Qiu, Feifei Lei, Gang Li & Boyu Du. (2021) Identification of new potential antigen recognized by γδT cells in hepatocellular carcinoma. Cancer Immunology, Immunotherapy 70:7, pages 1917-1927.
Crossref
Tao Wang, Qiting Zhang, Ning Wang, Ziqi Liu, Bin Zhang & Yufen Zhao. (2021) Research Progresses of Targeted Therapy and Immunotherapy for Hepatocellular Carcinoma. Current Medicinal Chemistry 28:16, pages 3107-3146.
Crossref
Yong He, Seonghwan Hwang, Yeni Ait Ahmed, Dechun Feng, Na Li, Marcelle Ribeiro, Fouad Lafdil, Tatiana Kisseleva, Gyongyi Szabo & Bin Gao. (2020) Immunopathobiology and therapeutic targets related to cytokines in liver diseases. Cellular & Molecular Immunology 18:1, pages 18-37.
Crossref
Jie Zan, Xuya Zhao, Xiya Deng, Hongda Ding, Bi Wang, Minyi Lu, Zijing Wei, Zhi Huang & Shuai Wang. (2021) Paraspeckle Promotes Hepatocellular Carcinoma Immune Escape by Sequestering IFNGR1 mRNA. Cellular and Molecular Gastroenterology and Hepatology 12:2, pages 465-487.
Crossref
Piera Federico, Angelica Petrillo, Pasqualina Giordano, Davide Bosso, Antonietta Fabbrocini, Margaret Ottaviano, Mario Rosanova, Antonia Silvestri, Andrea Tufo, Antonio Cozzolino & Bruno Daniele. (2020) Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Current Status and Novel Perspectives. Cancers 12:10, pages 3025.
Crossref
Keyur Patel, Ryan Lamm, Peter Altshuler, Hien Dang & Ashesh P. Shah. (2020) Hepatocellular Carcinoma—The Influence of Immunoanatomy and the Role of Immunotherapy. International Journal of Molecular Sciences 21:18, pages 6757.
Crossref
Hao‑Ying Wang, Yu‑Ping Wang, Xi Zeng, Ya Zheng, Qing‑Hong Guo, Rui Ji & Yong‑Ning Zhou. (2020) Circular RNA is a popular molecule in tumors of the digestive system (Review). International Journal of Oncology 57:1, pages 21-42.
Crossref
Yin Zongyi & Li Xiaowu. (2020) Immunotherapy for hepatocellular carcinoma. Cancer Letters 470, pages 8-17.
Crossref
Sara Gagno, Elena Poletto, Michele Bartoletti, Luca Quartuccio, Chiara Romualdi, Marica Garziera, Simona Scalone, Roberto Sorio, Eva Dreussi, Chiara Zanusso, Elena De Mattia, Rossana Roncato, Erika Cecchin, Giorgio Giorda, Salvatore De Vita, Michele Dal Bo, Fabio Puglisi & Giuseppe Toffoli. (2020) A TGF-β associated genetic score to define prognosis and platinum sensitivity in advanced epithelial ovarian cancer. Gynecologic Oncology 156:1, pages 233-242.
Crossref
Jilin Wang, Teddy Yang & Jie Xu. 2020. Regulation of Cancer Immune Checkpoints. Regulation of Cancer Immune Checkpoints 619 649 .
Chen Lu, Dawei Rong, Betty Zhang, Wubin Zheng, Xuehao Wang, Ziyi Chen & Weiwei Tang. (2019) Current perspectives on the immunosuppressive tumor microenvironment in hepatocellular carcinoma: challenges and opportunities. Molecular Cancer 18:1.
Crossref
Quirino Lai, Alessandro Vitale, Tommaso Manzia, Francesco Foschi, Giovanni Levi Sandri, Martina Gambato, Fabio Melandro, Francesco Russo, Luca Miele, Luca Viganò, Patrizia Burra & Edoardo Giannini. (2019) Platelets and Hepatocellular Cancer: Bridging the Bench to the Clinics. Cancers 11:10, pages 1568.
Crossref
Mossenta, Busato, Baboci, Cintio, Toffoli & Bo. (2019) New Insight into Therapies Targeting Angiogenesis in Hepatocellular Carcinoma. Cancers 11:8, pages 1086.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.